Sep 3, 2026
Bristol Myers Squibb halts autoimmune drug trials after deaths and life-threatening side effects
Bristol Myers Squibb paused closely watched autoimmune drug research in early June after reports of life-threatening side effects and deaths, notifying regulators, researchers and patient advocacy groups.
2 sources
00